 |
Trial Information
Summary: Trial Information: Weight Loss / DiabetesThe purpose of this research study is to examine the safety and effectiveness of 2 different doses of an investigational medication compared to placebo (an inactive substance) for treatment in obese volunteers with Type II diabetes. The study will last up to 62 weeks with 16 visits to our office and 1 follow up telephone call. At the first visit you will read and sign an informed consent form to participate in the study and a physical exam, EKG, blood pressure and pulse, and fasting lab tests. For more information, and to see if you qualify, call our office or visit our website www.rcrclinical.com.
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Trial listings updated: June 1, 2008 at 6:37:04 AM |
|
|
Patient Resources: [ Trial Listing
] [ Notification Services ] [ Drug
Directories ]
Copyright © 1995 - 2008, CenterWatch |
